nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abnormal B-cell development in TIMP-deficient bone marrow
|
Weiss, Ashley |
|
|
|
20 |
p. 3960-3974 |
artikel |
2 |
Abnormalities of bone marrow B cells and plasma cells in primary immune thrombocytopenia
|
Yu, Tian-shu |
|
|
|
20 |
p. 4087-4101 |
artikel |
3 |
Absolute proteome quantification of highly purified populations of circulating reticulocytes and mature erythrocytes
|
Gautier, Emilie-Fleur |
|
|
|
20 |
p. 2646-2657 |
artikel |
4 |
Activation status dictates the function of unlicensed natural killer cells in mice and humans
|
Aguilar, Ethan G. |
|
|
|
20 |
p. 4219-4232 |
artikel |
5 |
Acute myeloid leukemia–induced remodeling of the human bone marrow niche predicts clinical outcome
|
Chen, Yiyang |
|
|
|
20 |
p. 5257-5268 |
artikel |
6 |
Acute myeloid leukemia–induced T-cell suppression can be reversed by inhibition of the MAPK pathway
|
Moshofsky, Kaycee B. |
|
|
|
20 |
p. 3038-3051 |
artikel |
7 |
A decreased and less sustained desmopressin response in hemophilia A carriers contributes to bleeding
|
Candy, Victoria |
|
|
|
20 |
p. 2629-2636 |
artikel |
8 |
Adoptive immunotherapy with CB following chemotherapy for patients with refractory myeloid malignancy: chimerism and response
|
Chaekal, Ok-kyong |
|
|
|
20 |
p. 5146-5156 |
artikel |
9 |
Adoptive T-cell therapy for Hodgkin lymphoma
|
Ho, Carrie |
|
|
|
20 |
p. 4291-4302 |
artikel |
10 |
ADP: the missing link between thrombosis and hemolysis
|
Gerber, Gloria F. |
|
|
|
20 |
p. 6364-6366 |
artikel |
11 |
A feasibility randomized controlled trial of an mHealth app vs booklets for patient-facing guidelines in adults with SCD
|
Cronin, Robert M. |
|
|
|
20 |
p. 6184-6190 |
artikel |
12 |
Allogeneic transplantation for Ph+ acute lymphoblastic leukemia with posttransplantation cyclophosphamide
|
Webster, Jonathan A. |
|
|
|
20 |
p. 5078-5088 |
artikel |
13 |
Alquezar-Artieda N, Kuzilkova D, Roberts J, et al. Restored biosynthetic pathways induced by MSCs serve as rescue mechanism in leukemia cells after L-asparaginase therapy. Blood Adv. 2023;7(10):2228-2236.
|
|
|
|
|
20 |
p. 6023 |
artikel |
14 |
Altered microbiota-host metabolic cross talk preceding neutropenic fever in patients with acute leukemia
|
Rashidi, Armin |
|
|
|
20 |
p. 3937-3950 |
artikel |
15 |
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients
|
Cuker, Adam |
|
|
|
20 |
p. 3951-3959 |
artikel |
16 |
A new murine Rpl5 (uL18) mutation provides a unique model of variably penetrant Diamond-Blackfan anemia
|
Yu, Lei |
|
|
|
20 |
p. 4167-4178 |
artikel |
17 |
An in vitro model of human hematopoiesis identifies a regulatory role for the aryl hydrocarbon receptor
|
Khan, D M Isha Olive |
|
|
|
20 |
p. 6253-6265 |
artikel |
18 |
A novel GATA2 distal enhancer mutation results in MonoMAC syndrome in 2 second cousins
|
West, Robert R. |
|
|
|
20 |
p. 6351-6363 |
artikel |
19 |
A novel mechanism of thrombocytopenia by PS exposure through TMEM16F in sphingomyelin synthase 1 deficiency
|
Fujii, Yoritaka |
|
|
|
20 |
p. 4265-4277 |
artikel |
20 |
Antagonism of inhibitors of apoptosis proteins reveals a novel, immune response-based therapeutic approach for T-cell lymphoma
|
Ferrari, Nicola |
|
|
|
20 |
p. 4003-4016 |
artikel |
21 |
Anticoagulant therapy in patients with congenital FXI deficiency
|
Bravo-Pérez, Carlos |
|
|
|
20 |
p. 4083-4086 |
artikel |
22 |
Anti-myeloma efficacy of CAR-iNKT is enhanced with a long-acting IL-7, rhIL-7-hyFc
|
O’Neal, Julie |
|
|
|
20 |
p. 6009-6022 |
artikel |
23 |
A phase 1/2 study of thiotepa-based immunochemotherapy in relapsed/refractory primary CNS lymphoma: the TIER trial
|
Fox, Christopher P. |
|
|
|
20 |
p. 4073-4082 |
artikel |
24 |
Association between the HLA-DRB1*03:01-DQB1*02:01 haplotype and PF4/heparin antibodies
|
Zhang, Ray |
|
|
|
20 |
p. 3136-3142 |
artikel |
25 |
Association of ABO blood group with bleeding severity in patients with bleeding of unknown cause
|
Mehic, Dino |
|
|
|
20 |
p. 5157-5164 |
artikel |
26 |
A systematic review of the association between anti-β-2 glycoprotein I antibodies and APS manifestations
|
Jiang, Debbie |
|
|
|
20 |
p. 3931-3936 |
artikel |
27 |
BCL2L1 is associated with γ-globin gene expression
|
Dai, Yan |
|
|
|
20 |
p. 2995-3001 |
artikel |
28 |
Bleeding severity in patients with rare bleeding disorders: real-life data from the RBiN study
|
Saes, Joline L. |
|
|
|
20 |
p. 5025-5034 |
artikel |
29 |
Blood–brain barrier permeability in survivors of immune-mediated thrombotic thrombocytopenic purpura: a pilot study
|
Huang, Shih-Han Susan |
|
|
|
20 |
p. 4211-4218 |
artikel |
30 |
Blood transfusion trends in the United States: national inpatient sample, 2015 to 2018
|
Goel, Ruchika |
|
|
|
20 |
p. 4179-4184 |
artikel |
31 |
Bone marrow sites differently imprint dormancy and chemoresistance to T-cell acute lymphoblastic leukemia
|
Cahu, Xavier |
|
|
|
20 |
p. 1760-1772 |
artikel |
32 |
Cardiac involvement resolution is frequent and associated with improved outcome in Erdheim-Chester disease
|
Azoulay, Lévi-Dan |
|
|
|
20 |
p. 6130-6133 |
artikel |
33 |
CD19 CAR T-cell therapy demonstrates activity against extramedullary disease in pediatric patients with B-ALL
|
Epperly, Rebecca |
|
|
|
20 |
p. 6320-6324 |
artikel |
34 |
CD19-directed CAR T-cell therapy for treatment of primary CNS lymphoma
|
Siddiqi, Tanya |
|
|
|
20 |
p. 4059-4063 |
artikel |
35 |
Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia
|
Bejanyan, Nelli |
|
|
|
20 |
p. 3123-3131 |
artikel |
36 |
Class II HLA mismatch improves outcomes following haploidentical transplantation with posttransplant cyclophosphamide
|
Solomon, Scott R. |
|
|
|
20 |
p. 5311-5321 |
artikel |
37 |
ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants
|
Luo, Xi |
|
|
|
20 |
p. 2962-2979 |
artikel |
38 |
Clinical MDR1 inhibitors enhance Smac-mimetic bioavailability to kill murine LSCs and improve survival in AML models
|
Morrish, Emma |
|
|
|
20 |
p. 5062-5077 |
artikel |
39 |
Combined EZH2 and Bcl-2 inhibitors as precision therapy for genetically defined DLBCL subtypes
|
Scholze, Hanna |
|
|
|
20 |
p. 5226-5231 |
artikel |
40 |
Combining BCMA-targeting CAR T cells with TCR-engineered T-cell therapy to prevent immune escape of multiple myeloma
|
Wachsmann, Tassilo L. A. |
|
|
|
20 |
p. 6178-6183 |
artikel |
41 |
Comparison of haploidentical and umbilical cord blood transplantation after myeloablative conditioning
|
Wagner Jr, John E. |
|
|
|
20 |
p. 4064-4072 |
artikel |
42 |
Comparison of MHG and DZsig reveals shared biology and a core overlap group with inferior prognosis in DLBCL
|
Davies, John R. |
|
|
|
20 |
p. 6156-6162 |
artikel |
43 |
Comparison of thromboembolism outcomes in patients with sickle cell disease prescribed hormonal contraception
|
Bala, Natasha S. |
|
|
|
20 |
p. 6140-6150 |
artikel |
44 |
Comparison of 2-year outcomes with CAR T cells (ZUMA-1) vs salvage chemotherapy in refractory large B-cell lymphoma
|
Neelapu, Sattva S. |
|
|
|
20 |
p. 4149-4155 |
artikel |
45 |
Complement and platelets: prothrombotic cell activation requires membrane attack complex–induced release of danger signals
|
Mannes, Marco |
|
|
|
20 |
p. 6367-6380 |
artikel |
46 |
Complement-mediated thrombotic microangiopathy as a link between endothelial damage and steroid-refractory GVHD
|
Wall, Sarah A. |
|
|
|
20 |
p. 2619-2628 |
artikel |
47 |
Complete RHD next-generation sequencing: establishment of reference RHD alleles
|
Tounsi, Wajnat A. |
|
|
|
20 |
p. 2713-2723 |
artikel |
48 |
Cumulative incidence, risk factors, and management of atrial fibrillation in patients receiving ibrutinib
|
Wiczer, Tracy E. |
|
|
|
20 |
p. 1739-1748 |
artikel |
49 |
Cytogenetic intraclonal heterogeneity of plasma cell dyscrasia in AL amyloidosis as compared with multiple myeloma
|
Bochtler, Tilmann |
|
|
|
20 |
p. 2607-2618 |
artikel |
50 |
Defining a cohort of anemia-activated cis elements reveals a mechanism promoting erythroid precursor function
|
Zhou, Yichao |
|
|
|
20 |
p. 6325-6338 |
artikel |
51 |
Delineation of target expression profiles in CD34+/CD38− and CD34+/CD38+ stem and progenitor cells in AML and CML
|
Herrmann, Harald |
|
|
|
20 |
p. 5118-5132 |
artikel |
52 |
Diagnostic biomarkers to differentiate sepsis from cytokine release syndrome in critically ill children
|
Diorio, Caroline |
|
|
|
20 |
p. 5174-5183 |
artikel |
53 |
Digital pathology in pediatric nodular lymphocyte-predominant Hodgkin lymphoma: correlation with treatment response
|
Sereda, Sergej |
|
|
|
20 |
p. 6285-6289 |
artikel |
54 |
Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapies
|
Gorak, Edward J. |
|
|
|
20 |
p. 6120-6129 |
artikel |
55 |
Discovery of a novel genomic alteration that renders leukemic cells resistant to CD19-targeted immunotherapies
|
Ghobadi, Armin |
|
|
|
20 |
p. 5634-5640 |
artikel |
56 |
Doxorubicin and subsequent risk of cardiovascular diseases among survivors of diffuse large B-cell lymphoma in Hong Kong
|
Lee, Shing Fung |
|
|
|
20 |
p. 5107-5117 |
artikel |
57 |
Editorial Board
|
|
|
|
|
20 |
p. i |
artikel |
58 |
Editorial Board
|
|
|
|
|
20 |
p. i |
artikel |
59 |
Editorial Board
|
|
|
|
|
20 |
p. i |
artikel |
60 |
Editorial Board
|
|
|
|
|
20 |
p. i |
artikel |
61 |
Editorial Board
|
|
|
|
|
20 |
p. i |
artikel |
62 |
Editorial Board
|
|
|
|
|
20 |
p. i |
artikel |
63 |
Editorial Board
|
|
|
|
|
20 |
p. i |
artikel |
64 |
Emicizumab should be prescribed independent of immune tolerance induction
|
Le Quellec, Sandra |
|
|
|
20 |
p. 2783-2786 |
artikel |
65 |
Enrichment of BTK Leu528Trp mutations in patients with CLL on zanubrutinib: potential for pirtobrutinib cross-resistance
|
Blombery, Piers |
|
|
|
20 |
p. 5589-5592 |
artikel |
66 |
EPHB4 is a therapeutic target in AML and promotes leukemia cell survival via AKT
|
Merchant, Akil A. |
|
|
|
20 |
p. 1635-1644 |
artikel |
67 |
ETS1 is a novel transcriptional regulator of adult T-cell leukemia/lymphoma of North American descent
|
Luchtel, Rebecca A. |
|
|
|
20 |
p. 5613-5624 |
artikel |
68 |
Evaluation of allogeneic and autologous membrane-bound IL-21–expanded NK cells for chronic lymphocytic leukemia therapy
|
Yano, Max |
|
|
|
20 |
p. 5641-5654 |
artikel |
69 |
Excellent response to very-low-dose radiation (4 Gy) for indolent B-cell lymphomas: is 4 Gy suitable for curable patients?
|
Imber, Brandon S. |
|
|
|
20 |
p. 4185-4197 |
artikel |
70 |
Exogenous mitochondrial transfer and endogenous mitochondrial fission facilitate AML resistance to OxPhos inhibition
|
Saito, Kaori |
|
|
|
20 |
p. 4233-4255 |
artikel |
71 |
Ex vivo human HSC expansion requires coordination of cellular reprogramming with mitochondrial remodeling and p53 activation
|
Papa, Luena |
|
|
|
20 |
p. 2766-2779 |
artikel |
72 |
Feasibility trial for the management of severe acute malnutrition in older children with sickle cell anemia in Nigeria
|
Abdullahi, Shehu U. |
|
|
|
20 |
p. 6024-6034 |
artikel |
73 |
Five-year outcomes of the S1106 study of R-hyper-CVAD vs R-bendamustine in transplant-eligible patients with mantle cell lymphoma
|
Kamdar, Manali |
|
|
|
20 |
p. 3132-3135 |
artikel |
74 |
Follicular lymphoma and macrophages: impact of approved and novel therapies
|
Gouni, Sushanth |
|
|
|
20 |
p. 4303-4312 |
artikel |
75 |
Free interleukin-18 is elevated in CD22 CAR T-cell–associated hemophagocytic lymphohistiocytosis–like toxicities
|
Rocco, Joseph M. |
|
|
|
20 |
p. 6134-6139 |
artikel |
76 |
Frequent STAT3 mutations in CD8+ T cells from patients with pure red cell aplasia
|
Kawakami, Toru |
|
|
|
20 |
p. 2704-2712 |
artikel |
77 |
Front Matter
|
|
|
|
|
20 |
p. ii |
artikel |
78 |
Front Matter
|
|
|
|
|
20 |
p. ii |
artikel |
79 |
Gata2 haploinsufficiency promotes proliferation and functional decline of hematopoietic stem cells with myeloid bias during aging
|
Abdelfattah, Ali |
|
|
|
20 |
p. 4285-4290 |
artikel |
80 |
Gene expression profile predicts response to the combination of tosedostat and low-dose cytarabine in elderly AML
|
Visani, Giuseppe |
|
|
|
20 |
p. 5040-5049 |
artikel |
81 |
Generation and function of progenitor T cells from StemRegenin-1–expanded CD34+ human hematopoietic progenitor cells
|
Singh, Jastaranpreet |
|
|
|
20 |
p. 2934-2948 |
artikel |
82 |
Genetic association with B-cell acute lymphoblastic leukemia in allogeneic transplant patients differs by age and sex
|
Clay-Gilmour, Alyssa I. |
|
|
|
20 |
p. 1717-1728 |
artikel |
83 |
Genetic heterogeneity of cytogenetically normal AML with mutations of CEBPA
|
Konstandin, Nikola P. |
|
|
|
20 |
p. 2724-2731 |
artikel |
84 |
Genetic profiles of subcutaneous panniculitis-like T-cell lymphoma and clinicopathological impact of HAVCR2 mutations
|
Koh, Jiwon |
|
|
|
20 |
p. 3919-3930 |
artikel |
85 |
Gfi1aa and Gfi1b set the pace for primitive erythroblast differentiation from hemangioblasts in the zebrafish embryo
|
Moore, Chris |
|
|
|
20 |
p. 2589-2606 |
artikel |
86 |
Glycoprotein Ibα inhibitor (CCP-224) prevents neutrophil-platelet aggregation in sickle cell disease
|
Jimenez, Maritza A. |
|
|
|
20 |
p. 1712-1716 |
artikel |
87 |
Hepatic thrombopoietin gene silencing reduces platelet count and breast cancer progression in transgenic MMTV-PyMT mice
|
Shirai, Toshiaki |
|
|
|
20 |
p. 3080-3091 |
artikel |
88 |
Heterogeneous modulation of Bcl-2 family members and drug efflux mediate MCL-1 inhibitor resistance in multiple myeloma
|
Bolomsky, Arnold |
|
|
|
20 |
p. 4125-4139 |
artikel |
89 |
Heterozygous germ line CSF3R variants as risk alleles for development of hematologic malignancies
|
Trottier, Amy M. |
|
|
|
20 |
p. 5269-5284 |
artikel |
90 |
High-resolution architecture and partner genes of MYC rearrangements in lymphoma with DLBCL morphology
|
Chong, Lauren C. |
|
|
|
20 |
p. 2755-2765 |
artikel |
91 |
High-throughput microfluidic blood testing to phenotype genetically linked platelet disorders: an aid to diagnosis
|
Fernandez, Delia I. |
|
|
|
20 |
p. 6163-6177 |
artikel |
92 |
Horizontal meta-analysis identifies common deregulated genes across AML subgroups providing a robust prognostic signature
|
Nehme, Ali |
|
|
|
20 |
p. 5322-5335 |
artikel |
93 |
Human mutational constraint as a tool to understand biology of rare and emerging bone marrow failure syndromes
|
Oved, Joseph H. |
|
|
|
20 |
p. 5232-5245 |
artikel |
94 |
IBL-202 is synergistic with venetoclax in CLL under in vitro conditions that mimic the tumor microenvironment
|
Shen, Yandong |
|
|
|
20 |
p. 5093-5106 |
artikel |
95 |
ICOS is widely expressed in cutaneous T-cell lymphoma, and its targeting promotes potent killing of malignant cells
|
Amatore, Florent |
|
|
|
20 |
p. 5203-5214 |
artikel |
96 |
Identifying CD38+ cells in patients with multiple myeloma: first-in-human imaging using copper-64–labeled daratumumab
|
Krishnan, Amrita |
|
|
|
20 |
p. 5194-5202 |
artikel |
97 |
Impact of genomic alterations on outcomes in myelofibrosis patients undergoing JAK1/2 inhibitor therapy
|
Spiegel, Jay Y. |
|
|
|
20 |
p. 1729-1738 |
artikel |
98 |
Impaired natural killer cell counts and cytolytic activity in patients with severe COVID-19
|
Osman, Mohammed |
|
|
|
20 |
p. 5035-5039 |
artikel |
99 |
Implementing emicizumab in hemophilia inhibitor management: emicizumab should be prescribed after tolerance
|
Young, Guy |
|
|
|
20 |
p. 2780-2782 |
artikel |
100 |
Improved survival of patients with aggressive ATL by increased use of allo-HCT: a prospective observational study
|
Ito, Ayumu |
|
|
|
20 |
p. 4156-4166 |
artikel |
101 |
Incidence and predictors of priapism events in sickle cell anemia: a diary-based analysis
|
Idris, Ibrahim M. |
|
|
|
20 |
p. 5676-5683 |
artikel |
102 |
Induction of activated T follicular helper cells is critical for anti-FVIII inhibitor development in hemophilia A mice
|
Jing, Weiqing |
|
|
|
20 |
p. 3099-3110 |
artikel |
103 |
Infused wild-type macrophages reside and self-renew in the liver to rescue the hemolysis and anemia of Hmox1-deficient mice
|
Kim, Ki Soon |
|
|
|
20 |
p. 2732-2743 |
artikel |
104 |
In vitro evidence of complement activation in transplantation-associated thrombotic microangiopathy
|
Rotz, Seth J. |
|
|
|
20 |
p. 1632-1634 |
artikel |
105 |
Landscape of driver mutations and their clinical impacts in pediatric B-cell precursor acute lymphoblastic leukemia
|
Ueno, Hiroo |
|
|
|
20 |
p. 5165-5173 |
artikel |
106 |
Late-occurring venous thromboembolism in allogeneic blood or marrow transplant survivors: a BMTSS-HiGHS2 risk model
|
Gangaraju, Radhika |
|
|
|
20 |
p. 4102-4111 |
artikel |
107 |
Lee J, Zhang LL, Wu W, et al. Activation of MYC, a bona fide client of HSP90, contributes to intrinsic ibrutinib resistance in mantle cell lymphoma. Blood Adv. 2018;2(16):2039-2051.
|
|
|
|
|
20 |
p. 2588 |
artikel |
108 |
Liver fibrosis and its response to avapritinib in 2 patients with systemic mastocytosis
|
Cavazos, Karla |
|
|
|
20 |
p. 5630-5633 |
artikel |
109 |
Long-term outcome of hyper-CVAD-R for Burkitt leukemia/lymphoma and high-grade B-cell lymphoma: focus on CNS relapse
|
Samra, Bachar |
|
|
|
20 |
p. 3913-3918 |
artikel |
110 |
Loss of mDia1 causes neutropenia via attenuated CD11b endocytosis and increased neutrophil adhesion to the endothelium
|
Mei, Yang |
|
|
|
20 |
p. 1650-1656 |
artikel |
111 |
Management of heparin-induced thrombocytopenia: systematic reviews and meta-analyses
|
Morgan, Rebecca L. |
|
|
|
20 |
p. 5184-5193 |
artikel |
112 |
Mature murine megakaryocytes present antigen-MHC class I molecules to T cells and transfer them to platelets
|
Zufferey, Anne |
|
|
|
20 |
p. 1773-1785 |
artikel |
113 |
Megakaryocytes package contents into separate α-granules that are differentially distributed in platelets
|
Battinelli, Elisabeth M. |
|
|
|
20 |
p. 3092-3098 |
artikel |
114 |
MiR-146b-5p regulates IL-23 receptor complex expression in chronic lymphocytic leukemia cells
|
Matis, Serena |
|
|
|
20 |
p. 5593-5612 |
artikel |
115 |
Mogamulizumab for adult T-cell leukemia-lymphoma: a multicenter prospective observational study
|
Yonekura, Kentaro |
|
|
|
20 |
p. 5133-5145 |
artikel |
116 |
Molecular pathophysiology of the myelodysplastic syndromes: insights for targeted therapy
|
Aleshin, Alex |
|
|
|
20 |
p. 2787-2797 |
artikel |
117 |
Molecular response with blinatumomab in relapsed/refractory B-cell precursor acute lymphoblastic leukemia
|
Gökbuget, Nicola |
|
|
|
20 |
p. 3033-3037 |
artikel |
118 |
More intensive therapy has a better effect for frail parents with multiple myeloma
|
DuMontier, Clark |
|
|
|
20 |
p. 6275-6284 |
artikel |
119 |
Morphologic remission status is limited compared to ΔN flow cytometry: a Children's Oncology Group AAML0531 report
|
Brodersen, Lisa Eidenschink |
|
|
|
20 |
p. 5050-5061 |
artikel |
120 |
Mosunetuzumab in combination with CHOP in previously untreated DLBCL: safety and efficacy results from a phase 2 study
|
Olszewski, Adam J. |
|
|
|
20 |
p. 6055-6065 |
artikel |
121 |
MRTFA augments megakaryocyte maturation by enhancing the SRF regulatory axis
|
Rahman, Nur-Taz |
|
|
|
20 |
p. 2691-2703 |
artikel |
122 |
Multicenter phase 2 study of daratumumab monotherapy in patients with previously treated Waldenström macroglobulinemia
|
Castillo, Jorge J. |
|
|
|
20 |
p. 5089-5092 |
artikel |
123 |
Multiparameter phenotyping of platelet reactivity for stratification of human cohorts
|
Dunster, Joanne L. |
|
|
|
20 |
p. 4017-4030 |
artikel |
124 |
Myeloablative fractionated busulfan for allogeneic stem cell transplant in older patients or patients with comorbidities
|
Popat, Uday R. |
|
|
|
20 |
p. 6196-6205 |
artikel |
125 |
Myeloid leukemia factor 1 stabilizes tumor suppressor C/EBPα to prevent Trib1-driven acute myeloid leukemia
|
Nakamae, Ikuko |
|
|
|
20 |
p. 1682-1693 |
artikel |
126 |
Neurologic event–free survival demonstrates a benefit for SCID patients diagnosed by newborn screening
|
Dvorak, Christopher C. |
|
|
|
20 |
p. 1694-1698 |
artikel |
127 |
Next-generation sequencing–based monitoring of circulating tumor DNA reveals clonotypic heterogeneity in untreated PTCL
|
Miljkovic, Milos D. |
|
|
|
20 |
p. 4198-4210 |
artikel |
128 |
Next-generation sequencing of 35 RHD variants in 16 253 serologically D− pregnant women in the Finnish population
|
Tammi, Silja M. |
|
|
|
20 |
p. 4994-5001 |
artikel |
129 |
Nivolumab for relapsed/refractory classical Hodgkin lymphoma: 5-year survival from the pivotal phase 2 CheckMate 205 study
|
Ansell, Stephen M. |
|
|
|
20 |
p. 6266-6274 |
artikel |
130 |
Nonrelapse mortality among patients diagnosed with chronic GVHD: an updated analysis from the Chronic GVHD Consortium
|
DeFilipp, Zachariah |
|
|
|
20 |
p. 4278-4284 |
artikel |
131 |
Occurrence, thromboembolic risk, and mortality in Danish patients with cold agglutinin disease
|
Bylsma, Lauren C. |
|
|
|
20 |
p. 2980-2985 |
artikel |
132 |
Off-the-shelf CAR–engineered natural killer cells targeting FLT3 enhance killing of acute myeloid leukemia
|
Mansour, Anthony G. |
|
|
|
20 |
p. 6225-6239 |
artikel |
133 |
Oligomonocytic and overt chronic myelomonocytic leukemia show similar clinical, genomic, and immunophenotypic features
|
Calvo, Xavier |
|
|
|
20 |
p. 5285-5296 |
artikel |
134 |
Oncogenic role and therapeutic targeting of ABL-class and JAK-STAT activating kinase alterations in Ph-like ALL
|
Roberts, Kathryn G. |
|
|
|
20 |
p. 1657-1671 |
artikel |
135 |
Outcomes of axicabtagene ciloleucel in PMBCL compare favorably with those in DLBCL: a GLA/DRST registry study
|
Schubert, Maria-Luisa |
|
|
|
20 |
p. 6191-6195 |
artikel |
136 |
Outcomes of patients with CLL sequentially resistant to both BCL2 and BTK inhibition
|
Lew, Thomas E. |
|
|
|
20 |
p. 4054-4058 |
artikel |
137 |
Pediatric ALL relapses after allo-SCT show high individuality, clonal dynamics, selective pressure, and druggable targets
|
Hoell, Jessica I. |
|
|
|
20 |
p. 3143-3156 |
artikel |
138 |
Pegylated interferon-2α invokes graft-versus-leukemia effects in patients relapsing after allogeneic stem cell transplantation
|
Henden, Andrea S. |
|
|
|
20 |
p. 3013-3019 |
artikel |
139 |
Pharmacological DNA demethylation restores SMAD1 expression and tumor suppressive signaling in diffuse large B-cell lymphoma
|
Stelling, Anna |
|
|
|
20 |
p. 3020-3032 |
artikel |
140 |
Phase 2 study of ruxolitinib and decitabine in patients with myeloproliferative neoplasm in accelerated and blast phase
|
Mascarenhas, John O. |
|
|
|
20 |
p. 5246-5256 |
artikel |
141 |
Platelet binding to polymerizing fibrin is avidity driven and requires activated αIIbβ3 but not fibrin cross-linking
|
Buitrago, Lorena |
|
|
|
20 |
p. 3986-4002 |
artikel |
142 |
Platelets upregulate tumor cell programmed death ligand 1 in an epidermal growth factor receptor-dependent manner in vitro
|
Guo, Qiuchen |
|
|
|
20 |
p. 5668-5675 |
artikel |
143 |
Platelet variability index: a measure of platelet count fluctuations in patients with immune thrombocytopenia
|
Li, Na |
|
|
|
20 |
p. 4256-4264 |
artikel |
144 |
Population pharmacokinetic modeling of factor concentrates in hemophilia: an overview and evaluation of best practice
|
Goedhart, Tine M.H.J. |
|
|
|
20 |
p. 4314-4325 |
artikel |
145 |
Predictors of treatment response and survival outcomes in patients with advanced cardiac AL amyloidosis
|
Gustine, Joshua N. |
|
|
|
20 |
p. 6080-6091 |
artikel |
146 |
Pregnancy in women with an inferior vena cava filter: a tertiary center experience and overview of the literature
|
Bistervels, Ingrid M. |
|
|
|
20 |
p. 4044-4053 |
artikel |
147 |
Primary thromboprophylaxis in ambulatory cancer patients with a high Khorana score: a systematic review and meta-analysis
|
Bosch, Floris T.M. |
|
|
|
20 |
p. 5215-5225 |
artikel |
148 |
Primary treatment of light-chain amyloidosis with bortezomib, lenalidomide, and dexamethasone
|
Kastritis, Efstathios |
|
|
|
20 |
p. 3002-3009 |
artikel |
149 |
PRMT5 inhibition drives therapeutic vulnerability to combination treatment with BCL-2 inhibition in mantle cell lymphoma
|
Brown-Burke, Fiona |
|
|
|
20 |
p. 6211-6224 |
artikel |
150 |
Progenitor B-1 B-cell acute lymphoblastic leukemia is associated with collaborative mutations in 3 critical pathways
|
Gough, Sheryl M. |
|
|
|
20 |
p. 1749-1759 |
artikel |
151 |
Prognostic impact of low allelic ratio FLT3-ITD and NPM1 mutation in acute myeloid leukemia
|
Sakaguchi, Masahiro |
|
|
|
20 |
p. 2744-2754 |
artikel |
152 |
Racial disparities in access to alternative donor allografts persist in the era of “donors for all”
|
Fingrut, Warren B. |
|
|
|
20 |
p. 5625-5629 |
artikel |
153 |
Racial disparities in treatment patterns and outcomes among patients with multiple myeloma: a SEER-Medicare analysis
|
Ailawadhi, Sikander |
|
|
|
20 |
p. 2986-2994 |
artikel |
154 |
Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease
|
Field, Joshua J. |
|
|
|
20 |
p. 1645-1649 |
artikel |
155 |
Real-world experience of venetoclax with azacitidine for untreated patients with acute myeloid leukemia
|
Winters, Amanda C. |
|
|
|
20 |
p. 2911-2919 |
artikel |
156 |
Red cell alloimmunization is associated with increased health care costs, longer hospitalizations, and higher mortality
|
Viayna, Elisabet |
|
|
|
20 |
p. 5655-5658 |
artikel |
157 |
Reduced prevalence of SARS-CoV-2 infection in ABO blood group O
|
Barnkob, Mike Bogetofte |
|
|
|
20 |
p. 4990-4993 |
artikel |
158 |
Resistance mechanism to Notch inhibition and combination therapy in human T-cell acute lymphoblastic leukemia
|
Cao, Linlin |
|
|
|
20 |
p. 6240-6252 |
artikel |
159 |
Resistance to histone deacetylase inhibitors confers hypersensitivity to oncolytic reovirus therapy
|
Islam, Shariful |
|
|
|
20 |
p. 5297-5310 |
artikel |
160 |
Response to meta-analysis of leukocytosis and thrombosis in essential thrombocythemia and polycythemia vera
|
Ronner, Lukas |
|
|
|
20 |
p. 3010-3012 |
artikel |
161 |
Ring sideroblasts in AML are associated with adverse risk characteristics and have a distinct gene expression pattern
|
Berger, Gerbrig |
|
|
|
20 |
p. 3111-3122 |
artikel |
162 |
Role of the coagulation system in the pathogenesis of sickle cell disease
|
Nasimuzzaman, Md |
|
|
|
20 |
p. 3170-3180 |
artikel |
163 |
RUNX1 regulates site specificity of DNA demethylation by recruitment of DNA demethylation machineries in hematopoietic cells
|
Suzuki, Takahiro |
|
|
|
20 |
p. 1699-1711 |
artikel |
164 |
Safety and efficacy of atezolizumab with obinutuzumab and bendamustine in previously untreated follicular lymphoma
|
Younes, Anas |
|
|
|
20 |
p. 5659-5667 |
artikel |
165 |
Safety of allogeneic hematopoietic cell transplant in adults after CD19-targeted CAR T-cell therapy
|
Shadman, Mazyar |
|
|
|
20 |
p. 3062-3069 |
artikel |
166 |
Safety of a strategy combining D-dimer testing and whole-leg ultrasonography to rule out deep vein thrombosis
|
Fronas, Synne G. |
|
|
|
20 |
p. 5002-5010 |
artikel |
167 |
Samples from patients with AML show high concordance in detection of mutations by NGS at local institutions vs central laboratories
|
Borate, Uma |
|
|
|
20 |
p. 6048-6054 |
artikel |
168 |
Sensing of red blood cells with decreased membrane deformability by the human spleen
|
Safeukui, Innocent |
|
|
|
20 |
p. 2581-2587 |
artikel |
169 |
Serum Flt3 ligand is a biomarker of progenitor cell mass and prognosis in acute myeloid leukemia
|
Milne, Paul |
|
|
|
20 |
p. 3052-3061 |
artikel |
170 |
Severe reduction of free-form ADAMTS13, unbound to von Willebrand factor, in plasma of patients with HELLP syndrome
|
Yoshida, Yoko |
|
|
|
20 |
p. 1628-1631 |
artikel |
171 |
Significance of E-lesions in Hodgkin lymphoma and the creation of a new consensus definition: a report from SEARCH
|
Zijtregtop, Eline A. M. |
|
|
|
20 |
p. 6303-6319 |
artikel |
172 |
Similar outcomes of alemtuzumab-based hematopoietic cell transplantation for SAA patients older or younger than 50 years
|
Sheth, Vipul Sharad |
|
|
|
20 |
p. 3070-3079 |
artikel |
173 |
Small interfering RNA–mediated allele-selective silencing of von Willebrand factor in vitro and in vivo
|
Jongejan, Yvonne K. |
|
|
|
20 |
p. 6108-6119 |
artikel |
174 |
Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41
|
Homan, Claire C. |
|
|
|
20 |
p. 6092-6107 |
artikel |
175 |
Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study
|
Haverkos, Bradley |
|
|
|
20 |
p. 6339-6350 |
artikel |
176 |
Targeting chronic lymphocytic leukemia with N-methylated thrombospondin-1–derived peptides overcomes drug resistance
|
Pramil, Elodie |
|
|
|
20 |
p. 2920-2933 |
artikel |
177 |
The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19
|
Hoiland, Ryan L. |
|
|
|
20 |
p. 4981-4989 |
artikel |
178 |
The fate of mitochondria during platelet activation
|
Grichine, Alexei |
|
|
|
20 |
p. 6290-6302 |
artikel |
179 |
The impact of phlebotomy and hydroxyurea on survival and risk of thrombosis among older patients with polycythemia vera
|
Podoltsev, Nikolai A. |
|
|
|
20 |
p. 2681-2690 |
artikel |
180 |
The mutational landscape of accelerated- and blast-phase myeloproliferative neoplasms impacts patient outcomes
|
McNamara, Caroline J. |
|
|
|
20 |
p. 2658-2671 |
artikel |
181 |
The overlap of skin and blood T-cell clones in early-stage mycosis fungoides
|
Joffe, Daniel |
|
|
|
20 |
p. 6206-6210 |
artikel |
182 |
The platelet NLRP3 inflammasome is upregulated in sickle cell disease via HMGB1/TLR4 and Bruton tyrosine kinase
|
Vogel, Sebastian |
|
|
|
20 |
p. 2672-2680 |
artikel |
183 |
Therapy-related myeloid neoplasms in 109 patients after radiation monotherapy
|
Patel, Anand Ashwin |
|
|
|
20 |
p. 4140-4148 |
artikel |
184 |
The transcriptome of CMML monocytes is highly inflammatory and reflects leukemia-specific and age-related alterations
|
Franzini, Anca |
|
|
|
20 |
p. 2949-2961 |
artikel |
185 |
TLR7 ligation augments hematopoiesis in Rps14 (uS11) deficiency via paradoxical suppression of inflammatory signaling
|
Peña, Oscar A. |
|
|
|
20 |
p. 4112-4124 |
artikel |
186 |
TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML
|
Vadakekolathu, Jayakumar |
|
|
|
20 |
p. 5011-5024 |
artikel |
187 |
Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia
|
Shiba, Norio |
|
|
|
20 |
p. 3157-3169 |
artikel |
188 |
Transfusion of target antigens to preimmunized recipients: a new mechanism in transfusion-related acute lung injury
|
Bayat, Behnaz |
|
|
|
20 |
p. 3975-3985 |
artikel |
189 |
Treatment of allosensitized patients receiving allogeneic transplantation
|
Ciurea, Stefan O. |
|
|
|
20 |
p. 4031-4043 |
artikel |
190 |
Twist1 regulates embryonic hematopoietic differentiation through binding to Myb and Gata2 promoter regions
|
Kulkeaw, Kasem |
|
|
|
20 |
p. 1672-1681 |
artikel |
191 |
Ultrasensitive chimerism enhances measurable residual disease testing after allogeneic hematopoietic cell transplantation
|
Kanaan, Sami B. |
|
|
|
20 |
p. 6066-6079 |
artikel |
192 |
Uptake of long-chain fatty acids from the bone marrow suppresses CD8+ T-cell metabolism and function in multiple myeloma
|
Gudgeon, Nancy |
|
|
|
20 |
p. 6035-6047 |
artikel |
193 |
Use of flow cytometric light scattering to recognize the characteristic vacuolated marrow cells in VEXAS syndrome
|
Ding, Yanna |
|
|
|
20 |
p. 6151-6155 |
artikel |
194 |
Visualizing hematopoiesis as a stochastic process
|
Xu, Jason |
|
|
|
20 |
p. 2637-2645 |
artikel |
195 |
Why is AAV FVIII gene therapy not approved by the US Food and Drug Administration yet?
|
Arruda, Valder R. |
|
|
|
20 |
p. 4313 |
artikel |